₹125.79
Above FV▼ -40.5% against the close used
Model range ₹29.87 – ₹167.43
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.
Bear₹29.87Fair value₹125.79Bull₹167.43
FairClose
52-week traded range
52W low ₹68.2152W high ₹213.04
The 52-week range is measured from the stored price history, not estimated.
Trading above the consensus fair value
Iol Chem And Pharma Ltd closed at ₹211.43, 68.1% above the consensus fair value of ₹125.79 drawn from 7 valuation models.
Financial DNA score 37/100 — Average. P/E of 32.3x against the 20x sector multiple the P/E model uses.
Quantitative summary only — not investment advice.
DCF Valuation
₹29.87
-85.9%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=8%, r=10%, tg=3%, n=10yr
Graham Number
₹95.04
-55.0%
√(22.5 × EPS × BVPS)
EPS=4.69, BVPS=85.6 · outside Graham range (P/E 32.3, P/B 2.5) — asset-light, treat as a rough floor
P/E Fair Value
₹167.43
-20.8%
EPS × 35.7x (sector P/E)
EPS=4.69, Sector P/E=35.7x
EV/EBITDA
₹124.73
-41.0%
(EBITDA × 10x − Net Debt) ÷ Shares
EBITDA=3.5B
Book Value (P/B)
₹66.16
-68.7%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=85.6, ROE=8.4%, g=3%, r=10%
Reverse DCF
₹211.43
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 18.1% | Historical: 0%
Margin of Safety
₹73.09
-65.4%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=97.45, MoS=25%
Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.
Educational data only. Not a recommendation to buy, sell or hold any security.